Qatar vs Slovakia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Qatar
3 patients
in 2021
Slovakia
3 patients
in 2021
Qatar rank
117th
Slovakia rank
117th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Qatar
- Slovakia
How they compare
Qatar currently reports 3 patients against 3 patients in Slovakia, a difference of 0 patients.
The two have swapped places 6 times across 19 shared years of data; in 2003 it was Slovakia ahead.
Qatar ranks 117th and Slovakia ranks 117th of 183 countries.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2857 patients | 0.2857 patients | 0 patients | — |
| 2010s | 0.3 patients | 0.5 patients | 0.2 patients | Slovakia |
| 2020s | 2.5 patients | 2.5 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Qatar or Slovakia?
- Qatar, at 3 patients against 3 patients in Slovakia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Qatar and Slovakia?
- 0 patients, with Qatar ahead.
- How many years of comparable data are there for Qatar and Slovakia?
- 19 years are reported by both, from 2003 to 2021.
- How do Qatar and Slovakia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Qatar ranks 117th and Slovakia ranks 117th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.